EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

The co-occurrence of multimorbidity and polypharmacy among middle-aged and older adults in Canada: A cross-sectional study using the Canadian Longitudinal Study on Aging (CLSA) and the Canadian Primary Care Sentinel Surveillance Network (CPCSSN)

Kathryn Nicholson iD, Jennifer Salerno, Sayem Borhan, Benoit Cossette, Dale Guenter, Meredith Vanstone, John Queenan, Michelle Greiver, Michelle Howard iD, Amanda L Terry, Tyler Williamson, Lauren E Griffith und 3 weitere

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0312873 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS ONE, 2025. Verfasst von Kathryn Nicholson und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology & Biostatistics, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Polypharmacy, Multimorbidity, Aging. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is an increasing prevalence of multiple conditions (multimorbidity) and multiple medications (polypharmacy) across many populations. Previous literature has focused on the prevalence and impact of these health states separately, but there is a need to better understand their co-occurrence. Methods and findings This study reported on multimorbidity and polypharmacy among middle-aged and older adults in two national datasets: the Canadian Longitudinal Study on Aging (CLSA) and the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). Using consistent methodology, we conducted a cross-sectional analysis of CLSA participants and CPCSSN patients aged 45 to 85 years as of 2015. When multimorbidity was defined as two or more conditions, the prevalence was 66.7% and 52.0% in the CLSA and CPCSSN cohorts, respectively. The prevalence of polypharmacy was 14.9% in the CLSA cohort and 22.6% in the CPCSSN cohort when defined as five or more medications. Using the same cut-points, the co-occurrence of multimorbidity and polypharmacy was similar between the two cohorts (CLSA: 14.3%; CPCSSN: 13.5%). Approximately 20% of older adults (65 to 85 years) were living with both multimorbidity and polypharmacy (CLSA: 21.4%; CPCSSN: 18.3%), as compared to almost 10% of middle-aged adults (45 to 64 years) living with this co-occurrence (CLSA: 9.2%; CPCSSN: 9.9%). Across both cohorts and age groups, females had consistently higher estimates of multimorbidity, polypharmacy and the co-occurrence of multimorbidity and polypharmacy.

Conclusions

This study found that multimorbidity and polypharmacy are not interchangeable in understanding population health needs. Approximately one in five older adults in the CLSA and CPCSSN cohorts were living with both multimorbidity and polypharmacy, double the proportion in the younger cohorts. This has implications for future research, as well as health policy and clinical practice, that aim to reduce the occurrence and impact of multimorbidity and unnecessary polypharmacy to enhance the well-being of aging populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolypharmacyMultimorbidityAgingHumansAgedFemaleMiddle AgedCanadaMaleCross-Sectional StudiesAged, 80 and overLongitudinal StudiesSentinel SurveillancePrimary Health CarePrevalence

Autor:innen und Institutionen

  • Department of Epidemiology & Biostatistics, Western University, London, Ontario, Canada.
  • Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Department of Family Medicine, Queen's University, Kingston, Ontario, Canada.
  • Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Kathryn Nicholson, Michelle Howard

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Nicholson, K., Salerno, J., Borhan, S., Cossette, B., Guenter, D., Vanstone, M., Queenan, J., Greiver, M., Howard, M., Terry, A. L., Williamson, T., Griffith, L. E., Fortin, M., Stranges, S., & Mangin, D. (2025). The co-occurrence of multimorbidity and polypharmacy among middle-aged and older adults in Canada: A cross-sectional study using the Canadian Longitudinal Study on Aging (CLSA) and the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). PLOS ONE. https://doi.org/10.1371/journal.pone.0312873

Vancouver

Nicholson K, Salerno J, Borhan S, Cossette B, Guenter D, Vanstone M, et al. The co-occurrence of multimorbidity and polypharmacy among middle-aged and older adults in Canada: A cross-sectional study using the Canadian Longitudinal Study on Aging (CLSA) and the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). PLOS ONE. 2025. doi:10.1371/journal.pone.0312873

BibTeX
@article{Nicholson2025,
  author = {Nicholson, Kathryn and Salerno, Jennifer and Borhan, Sayem and Cossette, Benoit and Guenter, Dale and Vanstone, Meredith and Queenan, John and Greiver, Michelle and Howard, Michelle and Terry, Amanda L and Williamson, Tyler and Griffith, Lauren E and Fortin, Martin and Stranges, Saverio and Mangin, Dee},
  title = {The co-occurrence of multimorbidity and polypharmacy among middle-aged and older adults in Canada: A cross-sectional study using the Canadian Longitudinal Study on Aging (CLSA) and the Canadian Primary Care Sentinel Surveillance Network (CPCSSN)},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0312873}
}
Kostenlos starten →